18F-FDG-PET/CT in the assessment of pancreatic cancer: is the contrast or a better-designed trial needed?

dc.contributor.authorNguyen, Q.
dc.contributor.authorBartholomeusz, D.
dc.date.issued2011
dc.descriptionEditorial. Article first published online: 21 MAR 2011
dc.description.abstract<jats:p>See article in <jats:italic>J. Gastroenterol. Hepatol</jats:italic>. 2011; 26: 657–662.</jats:p>
dc.description.statementofresponsibilityNam Q Nguyen and Dylan F Bartholomeusz
dc.identifier.citationJournal of Gastroenterology and Hepatology, 2011; 26(4):613-615
dc.identifier.doi10.1111/j.1440-1746.2011.06625.x
dc.identifier.issn0815-9319
dc.identifier.issn1440-1746
dc.identifier.orcidNguyen, Q. [0000-0002-1270-5441]
dc.identifier.urihttp://hdl.handle.net/2440/91066
dc.language.isoen
dc.publisherBlackwell Publishing Asia
dc.rights© 2011 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd
dc.source.urihttps://doi.org/10.1111/j.1440-1746.2011.06625.x
dc.subjectHumans
dc.subjectPancreatic Neoplasms
dc.subjectFluorodeoxyglucose F18
dc.subjectContrast Media
dc.subjectRadiopharmaceuticals
dc.subjectImage Interpretation, Computer-Assisted
dc.subjectPositron-Emission Tomography
dc.subjectTomography, X-Ray Computed
dc.subjectImaging, Three-Dimensional
dc.subjectBiopsy
dc.subjectNeoplasm Staging
dc.subjectPreoperative Care
dc.subjectSensitivity and Specificity
dc.subjectPredictive Value of Tests
dc.subjectResearch Design
dc.title18F-FDG-PET/CT in the assessment of pancreatic cancer: is the contrast or a better-designed trial needed?
dc.typeJournal article
pubs.publication-statusPublished

Files